In the randomised breast cancer material studied here, decreased YAP1 expression was associated with increased proliferation in ER+ breast cancers (Table 2), indicating a discrepancy between the ER+ cell line model and primary breast cancer data. This evidence concerns the gene YAP1 and breast cancer.